MapLight Therapeutics, Inc. filed 2 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-06-18. Between them they name 2 people, with 1 appointment and 1 departure. Each change below is quoted from the filing and linked to it.
Every change, newest first
Appointed: Jonathan Gillis, Chief Financial Officer, effective 2026-06-18
In connection with the separation of Mr. Setia, the board of directors of the Company appointed Jonathan Gillis, the Company's Chief Administrative and Accounting Officer, as the Company's interim Chief Financial Officer and interim principal financial officer, effective June 18, 2026.
Departing: Robert Malenka
On April 23, 2026, Robert Malenka, M.D., Ph.D., and Jim Trenkle, Ph.D., notified the Board of Directors (the "Board") of MapLight Therapeutics, Inc. (the "Company") of their respective decisions not to stand for reelection at the Company's Annual Meeting of Stockholders to be held on June 23, 2026.
Find people with the same kind of experience as the Chief Financial Officer at MapLight Therapeutics, Inc., with the record behind each one.
Find candidates like Chief Financial Officer at MapLight Therapeutics, Inc.New leaders review vendors and budgets in their first months. Get an alert the next time MapLight Therapeutics, Inc. is in the news or changes leadership.
Get an alert when MapLight Therapeutics, Inc. changes leadershipTools for this story
Each opens in a new tab, filled in for MapLight Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.